Ipsen S.A. (EPA:IPN)
France
· Delayed Price · Currency is EUR 121.90
-0.50 (-0.41%)
At close: Dec 5, 2025
Ipsen Employees
Ipsen had 5,358 employees as of December 31, 2024. The number of employees increased by 33 or 0.62% compared to the previous year.
Employees
5,358
Change (1Y)
33
Growth (1Y)
0.62%
Revenue / Employee
€701,717
Profits / Employee
€83,595
Market Cap
10.01B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
| emeis Société anonyme | 83,494 |
Ipsen News
- 6 weeks ago - Ipsen S.A. (IPSEY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Ipsen S.A. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Ipsen S.A. reports Q3 results; upgrades FY outlook - Seeking Alpha
- 2 months ago - Ipsen Reports Positive Phase II Data For IPN10200 In Glabellar Lines, Shows Long-Lasting Efficacy - Nasdaq
- 2 months ago - Ipsen Secures Japanese Approval For Bylvay In Treating Pruritus - Nasdaq
- 3 months ago - Health Canada Approves Bylvay™ (odevixibat) for the treatment of cholestatic pruritus in patients with Alagille Syndrome - Benzinga
- 3 months ago - Ipsen S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) - GlobeNewsWire